“…It has been reported to have broad antiviral activities against human immunodeficiency virus, dengue virus, zika virus, human cytomegalovirus, human papilomavirus, hepatitis C virus, chikungunya virus, human influenza virus, respiratory syncytial virus, herpes simplex virus, SARS-CoV-2, and enteroviruses ( Hayashi et al, 2007 ; Mahata et al, 2011 ; Song et al, 2014 ; Shin et al, 2015 ; Warowicka et al, 2020 ; Varghese et al, 2021 ). In addition, BBR has been shown to cross the blood-brain barrier efficiently and exhibited neuroprotective effects in many neurological disorders ( Kulkarni and Dhir, 2010 ; Cheng et al, 2022 ). Therefore, BBR may hold promising efficacy for neuronal injury caused by EV71 infection.…”